FDA Approves Takeda’s Eohilia, an Oral Treatment for Eosinophilic Esophagitis

Takeda expects Eohilia single-dose stick packs will be available by the end of February for patients aged 11 years and older with eosinophilic esophagitis.

Source link
#FDA #Approves #Takedas #Eohilia #Oral #Treatment #Eosinophilic #Esophagitis